Article
CKS2 and RMI2 are two prognostic biomarkers of lung adenocarcinoma
7 Oct 2020
Abstract excerpt
BACKGROUND: Lung adenocarcinoma (ACA) is the most common subtype of non-small-cell lung cancer. About 70%-80% patients are diagnosed at an advanced stage; therefore, the survival rate is poor. It is urgent to discover accurate markers that can differentiate the late stages of lung ACA from the early stages. With the development of biochips, researchers are able to efficiently screen large amounts of biological...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
